ALLISON GINSBERG: Open Payments
NPI 1932221249 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 31 payments from 12 companies in 2025. Trend: 2023 $1,116 · 2024 $2,485 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 8 | $215 |
| Janssen Biotech, Inc. | 3 | $165 |
| Incyte Corporation | 4 | $161 |
| Amgen Inc. | 5 | $149 |
| GENZYME CORPORATION | 2 | $148 |
| Galderma Laboratories, L.P. | 3 | $48 |
| Lilly USA, LLC | 1 | $19 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
Products named: ANZUPGO, TREMFYA, OPZELURA, DUPIXENT, Otezla, ADBRY, EBGLYSS, Cabtreo.
Industry payments across NJ — which companies pay providers there.
